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Background: Impaired renal function may contribute to development of stroke and small vessel pathology in the brain. We 
investigated whether stroke subtype, initial stroke severity, early neurologic outcomes, time to cerebral infarction occurrence, 
and the presence of small vessel pathology in the brain are different between patients with end stage renal disease (ESRD) and 
those with renal transplantation (RT). Methods: A total of 57 consecutive de novo RT patients (RT group) and 120 patients un-
dergoing dialysis due to ESRD (ESRD group) who developed a first-ever acute cerebral infarction were enrolled. We compared 
stroke subtypes based on the Trial of Org 10172 in Acute Stroke Treatment classification, the presence of small vessel pathol-
ogy (cerebral microbleed, leukoaraiosis and silent lacunar infarction) on MRI, stroke severity based on the National Institutes 
of Health Stroke Scale (NIHSS) and in-hospital mortality between the groups. Results: The stroke subtypes, NIHSS scores at 
admission and in-hospital mortality were not different between the two groups. On multivariate analysis, the presence of high 
grade periventricular white matter changes tended to be more frequently detected in the ESRD group than the RT (P=0.078). 
The time from starting dialysis to stroke was longer in the RT group (129.9±60.9 months) than in the ESRD group (51.1±46.1 
months). Conclusion: The stroke patterns, severity and short term outcomes were not different between RT and ESRD. The risk 
of cerebral infarction and high grade periventricular white matter changes may be reduced after RT in patients with ESRD. (Ko-
rean J Stroke 2012;14:122-127)
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Introduction
Cerebral infarction occurs often in patients with end stage re-
nal disease (ESRD).1 Most patients with ESRD who are treated 
with hemodialysis (HD) have classic risk factors for ischemic 
stroke,2 and HD itself is an independent risk factor for stroke.2 
Patients who are treated with continuous ambulatory peritoneal 
dialysis (CAPD) may have a greater risk of ischemic and hem-
orrhagic strokes because high blood pressure is often less well 
controlled due to excessive hydration during CAPD.3 Cerebral 
small vessel pathology including silent lacunar infarction (SLI), 
leukoaraiosis (LA), and cerebral microbleeds (CMBs) were re-
ported as being associated with impaired renal function possibly 
due to the hemodynamic similarities between the vascular beds 
of the kidney and those of the brain.4-7
Renal transplantation (RT) is the best treatment for overcom-
ing many clinical problems associated with ESRD. Endothelial 
vascular damage and oxidative stress, which are caused by renal 
dysfunction and uremic toxin, are decreased after RT. Arterial 
stiffness, which is associated with small artery disease and intra-
cranial cerebral atherosclerosis, is improved.8-10 Additionally, the 
risk for vascular events is decreased in RT recipients with sus-
tained graft function.11 However, underlying vascular risk fac-
tors may be present in spite of RT, and the immunosuppressive 
agents that are used in patients with RT may aggravate vascular 
diseases and hypertension through catecholamine-related vaso-
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constriction.12 Therefore, RT may both positively and negatively 
affect stroke occurrence and outcomes. 
Considering that impaired renal function is associated with 
small vessel disease and that the renal function can be improved 
after RT, stroke types, small vessel pathologies and outcome may 
be different between ESRD patients who received RT and those 
who did not. There have been several reports on the characteris-
tics, incidence and classification of cerebral infarction in patients 
with ESRD2,13,14 and RT.15-19 However, no study has investigated 
differences in stroke type and outcomes between ESRD patients 
who received RT and those who did not. The aim of this study 
was to compare stroke subtype, initial stroke severity and early 
neurologic outcomes between these groups. We also investi-
gated whether the frequency of small vessel pathologies such as 
CMBs, SLI, and LA are different between the groups
Subjects and Methods
Study Subjects
We retrospectively reviewed medical records of patients treat-
ed with dialysis (HD or CAPD) or those who received a first (de 
novo) renal transplantation between January 1995 and January 
2011 at a single university hospital. Among the 2,321 patients 
who received a renal transplantation, 57 patients were identified 
as having a first-ever acute cerebral infarction. Among the 6,999 
ESRD patients treated with HD or CAPD during the same study 
period, 120 patients with a first-ever acute cerebral infarction 
were identified. All enrolled patients were confirmed as cerebral 
infarction by brain CT and/or magnetic resonance image. Pa-
tients with transient ischemic attack were excluded. This study 
was approved by the Severance Hospital Institutional Review 
Board of the Yonsei University Health System.
Study Group and Comparison Between the Groups
Demographic characteristics, laboratory findings, and time in-
tervals from the initiation of dialysis or RT to stroke onset were 
compared between patients with RT (RT group) and those under-
going dialysis due to ESRD but who did not receive RT (ESRD 
group). The stroke subtype was determined based on the Trial of 
Org 10172 in Acute Stroke Treatment (TOAST) classification20 
based on a neuroradiologist’s report and the consensus of stroke 
specialists. Severity of neurologic deficits was determined using 
the National Institutes of Health Stroke Scale (NIHSS) at admis-
sion. Data for in-hospital mortality was obtained from medical 
records.
Small artery pathologies were evaluated using MRI. CMBs 
were defined as punctuate hypointense lesions less than 10 mm 
in size on gradient echo (GRE) MRI images, which were based 
on previously reported methods.21 Silent lacunar infarction (SLI) 
was defined when a small (<15 mm) lesion in the perforating 
artery territory showed a high signal intensity on fluid attenuated 
inversion recovery (FLAIR) or T2 weighted and iso- or low sig-
nal intensity on T1 weighted image.22 We also assessed the sever-
ity of LA. The extents of LA in the periventricular white matter 
(PVWM) and deep white matter (DWM) were determined on 
the FLAIR images according to the Fazekas’ scoring system.23 
Briefly, LA in PVWM was categorized as: grade 0, absent; grade 
1, caps or pencil-thin lining; grade 2, smooth halo; and grade 
3, irregular PVWM extending into DWM. LA in DWM was 
categorized as: grade 0, absent; grade 1, punctuate foci; grade 2, 
beginning confluence of foci; and grade 3, large confluent areas. 
PVWM and DWM changes were dichotomized into high grade 
(2-3) or low grade (0-1) LA. 
Risk Factors
Hypertension was diagnosed when a patient had been taking 
anti-hypertensive medication or had resting systolic blood pres-
sures ≥140 mmHg or diastolic blood pressures ≥90 mmHg on 
repeated measurements. Diabetes mellitus was diagnosed if the 
patient had fasting blood glucose ≥7.0 mmol/L or was being 
treated with anti-diabetic medications or insulin. Hyperlipidemia 
was diagnosed if the patient had low-density lipoprotein cho-
lesterol ≥4.1 mmol/L, total cholesterol ≥6.2 mmol/L, or if the 
patient was treated with lipid lowering agents after diagnosis of 
hyperlipidemia. Patients were defined as smokers if they were 
current smokers or had stopped smoking within one year prior to 
the index ischemic stroke.
Statistical Analysis
Statistical analysis was performed with SPSS (version 18.0, 
SPSS Inc., Chicago, IL, USA). Continuous variables were re-
ported as mean ± standard deviation and categorical variables 
were reported as frequency and percentage. The variables were 
compared by independent t-tests, Chi-square tests, or Fisher’s 
exact test, as appropriate. A two-tailed value of P<0.05 was con-
sidered significant. Adjusting the age and sex factors, variables 
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with P<0.1 in the univariate analysis were entered for multivari-
ate binary logistic regression analyses were performed to deter-
mine independent factors for cerebral small vessel pathologies.
Results
Comparison of Demographic and Clinical Characteristics
The demographic data and the results of comparison for clini-
cal characteristics are shown in Table 1, 2. When compared 
with the RT group, the ESRD group was older, more frequently 
female, and had higher creatinine levels. Previous use of statins 
and hemodialysis were more frequently observed in the RT 
group. The cause of renal disease was different between the two 
groups in that chronic glomerular nephritis, including hyperten-
sive and diabetic nephropathy, was more frequently observed 
in the dialysis group while nephrotic syndrome was more fre-
quently observed in the RT group (Table 1). In the RT group, 
the mean time interval from starting dialysis to stroke onset was 
129.9±60.9 months, and that from RT to stroke onset was about 
102.2±60.3 months. These intervals were significantly longer 
than that in the ESRD group (51.1±46.1 months) (Table 2). 
Comparison of Stroke Subtypes and Small Vessel 
Pathology
Large artery atherosclerosis was most common in the RT 
group (31.6%) and small vessel occlusion was most common in 
the ESRD group (26.7%); however, there was no statistical dif-
ference between the two groups. Brain MRI was performed in 
160 (90.3%) patients (52 [91.2%] patients in the RT group and 
108 [90.0%] patients in the ESRD group). GRE images were 
available in 124 (70.0%) patients (44 [77.1%] patients in the RT 
group and 80 [66.7%] in the ESRD group).
On univariate logistic analysis, ESRD (P=0.018), high grade 
DWM changes (P=0.001), SLI (P=0.001), CMBs (P=0.001), 
older age (P=0.002) and diabetes mellitus (P=0.021) were asso-
ciated with high grade PVWM changes (Table 2). On multivari-
ate analysis, SLI and CMBs were not entered because of their 
multicollinearity with LA. After adjusting for sex and significant 
TABLE 1. Demographic data of renal transplantation and end stage renal disease
RT (n=57) ESRD (n=120) P-value
Sex, male 43 (75.4) 63 (52.5) 0.005
Age, yr 53.8±9.2 61.1±12.3 0.001
Risk factors
  Hypertension 54 (94.7) 108 (90.0) 0.392
  Diabetes mellitus 36 (63.2)   76 (63.3) 0.982
  Atrial fibrillation   7 (12.3)   24 (20.0) 0.290
  Dyslipidemia 29 (50.9)   49 (40.8) 0.209
  Smoking 13 (22.8)   19 (15.8) 0.260
  Coronary artery occlusive disease 14 (24.6)   53 (44.2) 0.012
  Previous statin use 39 (68.4)   46 (38.3) 0.001
  Previous antiplatelet medication 15 (26.3)   58 (48.3) 0.006
  Hemodialysis 48 (84.2)   67 (56.8) 0.001
Serum creatinine level, mg/dL 1.6±1.2 7.0±2.4 0.001
Serum albumin level, mg/dL 3.7±0.7 3.8±0.7 0.399
Causes of renal disease 0.001
  Chronic hypertensive nephropathy 22 (38.6) 43 (35.8)
  Diabetic nephropathy 5 (8.8) 5 (4.2)
  Hypertensive and diabetic nephropathy  11 (19.3) 68 (56.7)
  Primary nephrotic syndrome  12 (21.1) 2 (1.7)
  Eclampsia 3 (5.3) 0 (0.0)
  Tuberculous nephritis 2 (3.5) 0 (0.0)
  APCKD 1 (1.8) 1 (0.8)
  Drug induced 1 (1.8) 1 (0.8)
Data are shown as mean±SD, median (interquartile range), or number (%). RT: renal transplantation, ESRD: end stage renal 
disease, APCKD: adult polycystic kidney disease.
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factors on univariate analysis, ESRD tended to be associated 
with high grade PVMW changes (P=0.078) (Table 3). 
Comparison of Neurologic Severity and Outcomes
The NIHSS scores at admission did not differ between the RT 
and ESRD groups. In-hospital mortality (12 patients in RT ver-
sus 16 patients in ESRD, P=0.194) also did not differ between 
the two groups.
Discussion
This study showed that the high grade PVWM changes tended 
to be more frequently detected in ESRD patients than in RT 
patients. Our findings, along with findings in previous studies, 
suggest that impaired renal function is associated with small ves-
sel pathology in the brain,4-6 and its risk may be reduced when 
renal function is improved by RT. Arterial stiffness, which is 
associated with vessel wall damage in the microvessels of the 
end-organs and intracranial artery atherosclerosis, improved 
after RT.9,24 RT can improve endothelial dysfunction induced by 
a state of continuous renal dysfunction because uremic toxins 
cause oxidative stress on vasculature, endothelial damage, and 
acceleration of atherosclerosis.10,25 Those changes may underlie 
a decreased risk of small vessel pathologies following RT in 
ESRD patients. 
The incidences of stroke and cardiovascular disease were low-
er in the RT group than the ESRD group.26,27 Renal dysfunction 
increases the risk of ischemic and hemorrhagic stroke in the gen-
eral population.28 Function of kidney on admission appears to be 
a significant independent prognostic factor for long term mortal-
ity and new cardiovascular morbidity.29 In contrast, RT with sus-
tained graft function seems to reduce the risk for stroke.11 In this 
TABLE 3. Multivariate analysis for high grade periventricular white matter change and cerebral microbleeds
High grade PVWM change Cerebral microbleeds
OR (95% CI) P value OR (95% CI) P value
Sex 0.987 (0.500–1.950) 0.970 1.283 (0.511–3.211) 0.596
Age 1.043 (1.010–1.078) 0.011 1.055 (1.008–1.105) 0.021
Diabetes mellitus 2.585 (1.277–5.233) 0.008
ESRD 1.962 (0.962–4.155) 0.078 2.153 (0.698–6.640) 0.182
PVWM: periventricular white matter, OR: odds ratio, CI: confidence interval, ESRD: end stage renal disease.
TABLE 2. Clinical findings between renal transplantation and end stage renal disease
RT (n=57) ESRD (n=120) P-value
NIHSS at admission 3 (2-8) 3 (1-7) 0.565
Imaging findings
  High grade PVWMC 18 (34.6) 60 (55.6) 0.018
  High grade DWMC 17 (32.7) 52 (48.1) 0.088
  Silent lacunar infarction 22 (42.3) 64 (59.3) 0.062
  Cerebral microbleeds 5 (11.4) 23 (28.8) 0.042
In hospital mortality 12 (21.0) 19 (15.8) 0.194
TOAST classification 0.070
  Large artery atherosclerosis 18 (31.6) 25 (20.87)
  Cardioembolism 11 (19.2) 30 (25.0)
  Small vessel occlusion 10 (17.5) 32 (26.7)
  Undetermined negative 12 (21.1) 25 (20.8)
  Multiple causes 3 (5.3) 8 (6.7)
  Undetermined incomplete 3 (5.3) 0 (0.0)
Time interval from ESRD, months 129.9 ± 60.1 51.1 ± 46.1 0.001
Time interval from RT, months 102.2 ± 60.3
Data are shown as mean±SD, median (interquartile range), or number (%). RT: renal transplantation, ESRD: end stage renal 
disease, NIHSS: national Institutes of Health Stroke Scale, PVWMC: periventricular white matter change, DWMC: deep white 
matter change, TOAST: trial of Org 10172 in Acute Stroke Treatment.
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regard, recovery of renal dysfunction following RT could reduce 
the risk of stroke. The time from starting dialysis to stroke onset 
was longer in the RT group than in the ESRD group in our study. 
The longer time interval in the RT group might be related to the 
reduced risk of stroke following RT in patients with ESRD.
In our study, there were no differences in initial stroke severity 
and in-hospital mortality after stroke between the two groups. 
These findings suggest that stroke severity as well as short term 
outcomes were not substantially affected by renal transplantation 
and recovery of renal dysfunction, although stroke onset could 
be delayed. Renal dysfunction is associated with more severe 
stroke at admission and is a strong negative predictor of 30-day 
survival after acute ischemic stroke.30,31 Although renal trans-
plantation may improve clinical outcomes by improving renal 
and endothelial function,10 which may positively affect stroke 
severity, the use of immunosuppressive agents may produce 
neurotoxicity,24 which may offset the protective effect of RT. The 
small sample size in our study may be in part responsible for the 
absence of differences between the groups.
Our study has limitations. First, the size of population of our 
study was not large, which might be due to few events of cere-
bral infarction in both RT and dialysis patients. Therefore, all 
subtypes of stroke might not be represented sufficiently for the 
purpose of our study which includes comparison of the differ-
ences in occurrence of stroke subtypes between the groups. Sec-
ond, although the longer time intervals from starting dialysis to 
stroke onset in the RT group in our study were speculated to be 
associated with a reduced risk of stroke after RT, the incidence of 
stroke could not be investigated by our study design. Therefore, 
our speculation regarding this issue is inconclusive and further 
studies may be necessary to determine whether RT is protective 
for stroke.
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